Colin Cameron

Research Professor

The University of Texas at Arlington

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Colin Cameron is a Research Professor at The University of Texas at Arlington, USA. His research focuses on photodynamic therapy, the synthesis of novel iridium and ruthenium complexes, and their applications in cancer treatment. Recent articles highlight his work on hypoxia-active photosensitizers and the development of formulations for enhanced optical imaging and therapeutic efficacy.

Articles (14)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (9)

Craig McCormick

Professor

Dalhousie University Faculty of Medicine

CANADA

View details

Girgis Obaid

Assistant Professor

University of Texas at Dallas

UNITED STATES

View details

Gal Shafirstein

Professor of Oncology & Director of PDT Clinical Research

Roswell Park Comprehensive Cancer Center

UNITED STATES

View details

Edith Glazer

Professor

North Carolina State University

UNITED STATES

View details

Eric S. Pringle

Dalhousie University

CANADA

View details

Svetlana Kilina

North Dakota State University

UNITED STATES

View details

Sherri McFarland

Professor

The University of Texas at Arlington

UNITED STATES

View details

Marta Erminia Alberto

Associate Professor

University of Calabria

ITALY

View details

David Heidary

Research Professor

North Carolina State University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Colin Cameron

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

Increasing the Dye Payload of Cetuximab-IRDye800CW Enables Photodynamic Therapy

Ru(II) Oligothienyl Complexes with Fluorinated Ligands: Photophysical, Electrochemical, and Photobiological Properties

Hypoxia-Active Iridium(III) Bis-terpyridine Complexes Bearing Oligothienyl Substituents: Synthesis, Photophysics, and Phototoxicity toward Cancer Cells

Establishing a Robust and Reliable Response from a Potent Osmium‐Based Photosensitizer Via Lipid Nanoformulation†

Ru(II) Phenanthroline-Based Oligothienyl Complexes as Phototherapy Agents

Photodynamic Inactivation of Human Coronaviruses

Enabling In Vivo Optical Imaging of an Osmium Photosensitizer by Micellar Formulation

Anticancer Agent with Inexplicable Potency in Extreme Hypoxia: Characterizing a Light-Triggered Ruthenium Ubertoxin

Intraligand Excited States Turn a Ruthenium Oligothiophene Complex into a Light-Triggered Ubertoxin with Anticancer Effects in Extreme Hypoxia

Interaction with a Biomolecule Facilitates the Formation of the Function-Determining Long-Lived Triplet State in a Ruthenium Complex for Photodynamic Therapy

Fine‐Feature Modifications to Strained Ruthenium Complexes Radically Alter Their Hypoxic Anticancer Activity †

Ruthenium Photosensitizers for NIR PDT Require Lowest-Lying Triplet Intraligand (3IL) Excited States

String-Attached Oligothiophene Substituents Determine the Fate of Excited States in Ruthenium Complexes for Photodynamic Therapy

It Takes Three to Tango: The Length of the Oligothiophene Chain Determines the Nature of the Long‐Lived Excited State and the Resulting Photocytotoxicity of a Ruthenium(II) Photodrug

Collaborators (9)

Craig McCormick

Girgis Obaid

Gal Shafirstein

Edith Glazer

Eric S. Pringle

Svetlana Kilina

Sherri McFarland

Marta Erminia Alberto

David Heidary

Make your next move.